Tyler-Stone Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
1,988
+6
+0.3% +$4.66K 0.25% 78
2025
Q1
$1.64M Buy
1,982
+418
+27% +$348K 0.29% 69
2024
Q4
$1.21M Buy
1,564
+439
+39% +$363K 0.21% 85
2024
Q3
$997K Buy
1,125
+811
+258% +$729K 0.19% 108
2024
Q2
$284K Sell
314
-37
-11% -$29.6K 0.12% 150
2024
Q1
$273K Buy
351
+96
+38% +$68.3K 0.12% 154
2023
Q4
$149K Sell
255
-17
-6% -$9.92K 0.07% 207
2023
Q3
$146K Hold
272
0.08% 193
2023
Q2
$128K Buy
+272
New +$114K 0.07% 218
2022
Q4
$110K Hold
302
0.07% 223
2022
Q3
$98K Sell
302
-5,100
-94% -$1.62M 0.07% 222
2022
Q2
$1.75M Sell
5,402
-5
-0.1% -$1.5K 1.17% 22
2022
Q1
$1.55M Hold
5,407
0.85% 28
2021
Q4
$1.49M Buy
+5,407
New +$1.37M 0.79% 29

Other funds holding LLY

Tyler-Stone Wealth Management's LLY Position: Q2 2025 in Review

Tyler-Stone Wealth Management increased its Eli Lilly (LLY) stake by 0.3% in Q2 2025, buying an estimated $4.66K and bringing the position to 1,988 shares worth $1.55M. The position accounts for 0.25% of the portfolio, ranked #78.

Tyler-Stone Wealth Management first reported a position in LLY in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.75M in Q2 2022. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Tyler-Stone Wealth Management held 1,988 shares of Eli Lilly worth $1.55M as of Q2 2025.
  • Tyler-Stone Wealth Management bought 6 Eli Lilly shares in Q2 2025, an estimated $4.66K.
  • Eli Lilly made up 0.25% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #78 holding.
  • Tyler-Stone Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 14 quarters since.
  • Tyler-Stone Wealth Management's Eli Lilly position peaked at $1.75M in Q2 2022.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.